Botulinum toxin type A, the active ingredient in Dysport (abobotulinumtoxinA), is a purified neurotoxin type A complex produced by fermentation of the bacterium Clostridium botulinum type A, Hall Strain. It is purified from the culture supernatant by a series of precipitation, dialysis, and chromatography steps. The neurotoxin complex is composed of the neurotoxin, hemagglutinin proteins and non-toxin non-hemagglutinin protein.

Dysport is supplied in a single-use, sterile vial for reconstitution intended for intramuscular injection. Each vial contains 500 or 300 Units of lyophilized abobotulinumtoxinA, 125 micrograms human serum albumin and 2.5 mg lactose. Dysport may contain trace amounts of cow's milk proteins.

One unit of Dysport corresponds to the calculated median lethal intraperitoneal dose (LD50) in mice. The method for performing the assay is specific to Ipsen's product Dysport. Due to differences in specific details such as vehicle, dilution scheme and laboratory protocols for various mouse LD50 assays, Units of biological activity of Dysport are not interchangeable with Units of any other botulinum toxin or any toxin assessed with any other specific assay method.

Benefits:

- Reduces wrinkles

- Reduce and fix the face.

- Lifting the face.

- Reduced muscle function. Allows smaller muscles.

- Reduce the secretion of sweat.